These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37021171)

  • 21. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.
    Burgos AM; Saver JL
    Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis.
    Ma P; Zhang Y; Chang L; Li X; Diao Y; Chang H; Hui L
    J Neurol; 2022 Oct; 269(10):5262-5271. PubMed ID: 35776193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials.
    Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu T; Shah D; Bailey P; Dewey HM; Choi PMC; Ma A; Wijeratne T; Garcia-Esperon C; Cloud G; Chandra RV; Cordato DJ; Yan B; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2023 May; 100(18):e1900-e1911. PubMed ID: 36878701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.
    Rønning OM; Logallo N; Thommessen B; Tobro H; Novotny V; Kvistad CE; Aamodt AH; Næss H; Waje-Andreassen U; Thomassen L
    Stroke; 2019 Feb; 50(2):498-500. PubMed ID: 30602354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.
    Wang Y; Li S; Pan Y; Li H; Parsons MW; Campbell BCV; Schwamm LH; Fisher M; Che F; Dai H; Li D; Li R; Wang J; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X;
    Lancet; 2023 Feb; 401(10377):645-654. PubMed ID: 36774935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenecteplase Versus Alteplase for Acute Stroke: Mortality and Bleeding Complications.
    Murphy LR; Hill TP; Paul K; Talbott M; Golovko G; Shaltoni H; Jehle D
    Ann Emerg Med; 2023 Dec; 82(6):720-728. PubMed ID: 37178103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of different doses of tenecteplase in the treatment of acute ischemic stroke: A protocol for systematic review and meta-analysis.
    Chen G; Bai C; Zhu Z; Li J; Shao S
    Medicine (Baltimore); 2021 Jan; 100(3):e23805. PubMed ID: 33545944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes and safety profile of Tenecteplase in wake-up stroke.
    Ahmed HK; Logallo N; Thomassen L; Novotny V; Mathisen SM; Kurz MW
    Acta Neurol Scand; 2020 Nov; 142(5):475-479. PubMed ID: 32511749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.
    Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM
    Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis.
    Oliveira M; Fidalgo M; Fontão L; Antão J; Marques S; Afreixo V; Gregório T
    Am J Emerg Med; 2021 Apr; 42():31-37. PubMed ID: 33440328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.
    Roaldsen MB; Eltoft A; Wilsgaard T; Christensen H; Engelter ST; Indredavik B; Jatužis D; Karelis G; Kõrv J; Lundström E; Petersson J; Putaala J; Søyland MH; Tveiten A; Bivard A; Johnsen SH; Mazya MV; Werring DJ; Wu TY; De Marchis GM; Robinson TG; Mathiesen EB;
    Lancet Neurol; 2023 Feb; 22(2):117-126. PubMed ID: 36549308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials.
    Tornyos D; Komócsi A; Bálint A; Kupó P; El Abdallaoui OEA; Szapáry L; Szapáry LB
    PLoS One; 2022; 17(8):e0273103. PubMed ID: 35976963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
    Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial.
    Haley EC; Thompson JL; Grotta JC; Lyden PD; Hemmen TG; Brown DL; Fanale C; Libman R; Kwiatkowski TG; Llinas RH; Levine SR; Johnston KC; Buchsbaum R; Levy G; Levin B;
    Stroke; 2010 Apr; 41(4):707-11. PubMed ID: 20185783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
    Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
    Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-Term Efficacy Outcomes of Tenecteplase versus Alteplase for Acute Ischemic Stroke: A Meta-Analysis of 5 Randomized Trials.
    Requiao LE; Oliveira RS; Reis LS; B Assis AP; G Moreno BN; Cordeiro LR; Solla DF
    Neurol India; 2022; 70(4):1454-1459. PubMed ID: 36076643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review.
    Potla N; Ganti L
    Int J Emerg Med; 2022 Jan; 15(1):1. PubMed ID: 34983359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.